Non-decompensated cirrhosis as a risk factor for invasive aspergillosis: A case report and review of the immune dysfunction of cirrhosis

American Journal of the Medical Sciences

Volumn 334, Issue 4, 2007, Pages 314-316

  Lipke, Anne B ^a   Mihas, Anastasios A ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Immune deficiency; Invasive aspergillosis; Liver cirrhosis; Risk factors

Indexed keywords

ADULT; ASPERGILLOSIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE PREDISPOSITION; HOSPITAL; HUMAN; HUMAN TISSUE; IMMUNOPATHOLOGY; LABORATORY TEST; LIVER CIRRHOSIS; MALE; NEUROLOGIC EXAMINATION; PHYSICAL EXAMINATION; REVIEW; RISK; RISK FACTOR; ASPERGILLUS FUMIGATUS; IMMUNE SYSTEM; IMMUNOLOGY; LIVER; MICROBIOLOGY; MIDDLE AGED; PATHOGENICITY; PATHOLOGY; PATHOPHYSIOLOGY;

ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; HUMANS; IMMUNE SYSTEM; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 38449115202     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e318068d79c     Document Type: Article

References (22)

1. Latge J.P. Aspergillus fumigatus and Aspergillosis Clin Microbiol Rev 12 1999 310 350
2. Denning D.W. Therapeutic outcome in invasive aspergillosis Clin Infect Dis 23 1996 608 615
3. Meersseman W. Vandecasteele S.J. Wilmer A. Invasive aspergillosis in critically ill patients without malignancy Am J Respir Crit Care Med 170 2004 621 625
4. Dimopoulos G. Piagnerelli M. Berre J. Disseminated aspergillosis in intensive care unit patients: an autopsy study J Chemother 15 2003 71 75
5. Vandewoude K. Blot S. Benoit D. Invasive aspergillosis in critically ill patients: analysis of risk factors for acquisition and mortality Acta Clinica Belgica 59 2004 251 257
6. Segal B.H. Walsh T.J. Current approaches to diagnosis and treatment of invasive aspergillosis Am J Respir Crit Care Med 173 2006 707 717
7. Denning D.W. Invasive aspergillosis Clin Infect Dis 26 1998 781 802
8. Hartemink K.J. Paul M.A. Spijkstra J.J. Immunoparalysis as a cause for invasive aspergillosis? Intensive Care Med 29 2003 2068 2071
9. Panasiuk A. Wysocka J. Maciorkowska E. Phagocytic and oxidative burst activity of neutrophils in the end stage of liver cirrhosis World J Gastroenterol 11 2005 7661 7665
10. Fiuza C. Salcedo M. Clemente G. In vivo neutrophil dysfunction in cirrhotic patients with advanced liver disease J Infect Dis 182 2000 526 533
11. Gomez F. Ruiz P. Schreiber A.D. Impaired function of macrophage Fc gamma receptors and bacterial infection in alcoholic cirrhosis N Engl J Med 331 1994 1122 1128
12. Wyke R.J. Rajkovic I.A. Williams R. Impaired opsonization by serum from patients with chronic liver disease Clin Exp Immunol 51 1983 91 98
13. Vilstrup H. Cirrhosis and bacterial infections Rom J Gastroenterol 12 2003 297 302
14. Lombardo L. Capaldi A. Poccardi G. Peripheral blood CD3 and CD4 T-lymphocyte reduction correlates with severity of liver cirrhosis Int J Clin Lab Res 25 1995 153 156
15. Kiyici M. Nak S.G. Budak F. Lymphocyte subsets and cytokines in ascitic fluid of decompensated cirrhotic patients with and without spontaneous ascites infection J Gastroenterol Hepatol 21 2006 963 969
16. Denning D.W. Aspergillosis in “nonimmunocompromised” critically ill patients Am J Respir Crit Care Med 170 2004 580 581
17. Horvath J.A. Dummer S. The use of respiratory tract cultures in the diagnosis of invasive pulmonary aspergillosis Am J Med 100 1996 171 178
18. Levine S.L. An approach to the diagnosis of pulmonary infections in immunosuppressed patients Semin Respir Infect 7 1992 81 95
19. Hope W.W. Walsh T.J. Denning D.W. Laboratory diagnosis of invasive aspergillosis Lancet Infect Dis 5 2005 609 622
20. Ferns R.B. Evaluation of the role of real time PCR in the diagnosis of invasive aspergillosis Leuk Lymphoma 47 2006 15 20
21. White P.L. Linton C.J. Perry M.D. The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting Clin Infect Dis 15 2006 479 486
22. Geller S.A. Autopsy rate Hum Pathol 17 1986 535